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Early diagnosis of kidney diseases in avian species is limited. Endogenous markers currently used in 
avian practice are not sensitive enough to identify early kidney failure. Consequently, alternative 
markers should be evaluated. To be able to evaluate these alternative markers, an accurate marker 
to estimate the GFR should be validated. This study determined the GFR, measured as clearance of 
exogenous creatinine and exo-iohexol, in six different bird species, i.e. broiler chickens, laying chickens, 
turkeys, Muscovy ducks, pigeons and African grey parrots (4 /4 ). To be able to compare the six bird 
species, normalization to bodyweight (BW) of the GFR was performed, after a good correlation between 
BW and kidney weight was demonstrated (R² = 0.9836). Clearance of exo-iohexol normalized to BW 
(mL/min/kg) was determined in all bird species, i.e. 3.09 in broiler chickens; 2.57 in laying chickens; 
1.94 in turkeys; 1.29 in pigeons; 2.60 in ducks and 1.11 in parrots. However, these results differed 
significantly with the clearance of exogenous creatinine: 8.41 in broiler chickens; 9.33 in laying chickens; 
5.62 in turkeys; 14.97 in pigeons; 17.59 in ducks and 25.56 in parrots 25.56. Iohexol is preferred to 
measure the GFR, since it is not prone to tubular reabsorption nor secretion.
Renal disease in avian species is frequently encountered in clinical practice (approximately 30% of all disease con-
ditions) and can be caused by a large number of disease processes, such as dehydration, hypovitaminosis A, heavy 
metal toxicity, mycotoxic nephropathy (ochratoxin A), infectious diseases, renal lipidosis, amyloidosis, and renal 
carcinoma1,2. Kidneys are dynamic organs which are directly or indirectly associated with multiple body systems. 
As a result, renal disorders can lead to or be the result of multiple other disease processes2. The ante mortem diag-
nosis of renal disorders in birds is challenging as pathognomonic signs are rare3. Furthermore, early diagnosis 
of kidney diseases in avian species is limited because most of the commonly used markers, i.e. uric acid, are not 
sensitive enough to detect renal failure and urine collection is difficult to perform under clinical conditions2.
In humans and mammalian species, assessment of the glomerular filtration rate (GFR) is considered as the 
gold standard to evaluate the kidney function4,5. Accurate assessment of the GFR in human and veterinary 
research is essential for early detection of renal failure. Extrapolation of the GFR from mammals to birds is not 
recommended, since the gross external morphology of the avian kidneys differs from mammalian kidneys or the 
snake kidneys, but closely resembles the external morphology of chelonian and saurian reptiles kidneys. Two 
types of nephrons can be distinguished in the avian kidney, namely cortical or reptilian-type (70–90%, simple 
nephrons without loops of Henle) and medullary or mammalian-type nephrons (10–30%, complex nephrons 
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with loops of Henle)6. The avian kidney is not comparable to the mammalian kidney and the mammalian-type 
nephrons are less prone to a decrease in GFR in comparison with the reptilian-type nephrons. Therefore, the 
assessment of the GFR should be specifically evaluated in avian species5.
To date, information about the GFR in different avian species is rather scarce. Only a couple of scientific reports 
mention the determination of the GFR in specific bird species. Moreover, to the authors’ knowledge, no research 
has been done about the correlation of the GFR among different avian species, whereby it is not known if the GFR 
obtained in one avian species might be extrapolated to other avian species. Skadhauge and Schmidt-Nielsen7, 
Braun and Dantzler8, Wideman et al.9 and Gerson and Guglielmo10 measured the GFR, based on inulin admin-
istration, in domestic fowls (Gallus gallus dom., bodyweight (BW): 1–3 kg, GFR: 1.73–2.12 mL/min/kg), 
desert quails (Lophortyx gambelii, BW: 140–160 g, GFR: 0.88 mL/min/kg), broiler chickens (Gallus gallus dom., dif-
ferent ages: 1, 3, 5, 9, 12, 21 and 30 weeks, GFR: 2.58–3.15 mL/min/kg) and Swainson’s thrushes (Catharus ustulatus, 
BW: 30 g, GFR: 16.82 mL/h), respectively. Goldstein and Rothschild11 assessed the GFR, based on polyethylene 
glycol administration, in captive and wild song sparrows (BW: 18.4 ± 2 g, GFR: 5.3–9.0 mL/h). Scope et al.5 deter-
mined the GFR by exogenous creatinine administration in racing pigeons (Columba livia, BW: 491 ± 42 g, GFR 
IV: 6.30 mL/min/kg, GFR IM: 6.44 mL/min/kg). The authors concluded that both intravenous (IV) as well as 
intramuscular (IM) administration of exogenous creatinine accurately predicted the GFR in pigeons.
Since the GFR cannot be measured directly, assessment of the GFR is performed using clearance markers. 
To date, the frequently used endogenous biomarkers in veterinary practice, namely serum concentrations of 
creatinine, uric acid or urea and urine specific gravity, are not sensitive enough to detect early kidney dysfunc-
tion2. Consequently, alternative endogenous biomarkers, such as cystatin C, symmetric demethylarginine or 
N-acetyl-β-D-glucosaminidase, should be evaluated. In order to evaluate if these markers are sensitive enough 
to detect early renal failure, a reference standard clearance marker to accurately predict the GFR in avian species 
should be validated. The ideal clearance marker for GFR determination should be freely filtered by the glomeru-
lus, safe, inexpensive and not subjected to tubular reabsorption, tubular secretion nor plasma protein binding12. 
Renal clearance of inulin has been widely acknowledged as the gold standard in measuring the GFR in both 
human and veterinary research. However, determination of inulin clearance is costly, time-consuming and diffi-
cult to perform since IV infusion and timed urine collections are required. Therefore, alternative clearance mark-
ers such as the non-ionic contrast agent iohexol and exogenous creatinine have been proposed. Determination 
of iohexol and creatinine clearance are easily performed, since they do not require urine collection (difficult to 
perform in avian species, because urine is excreted together with faeces) or specialized equipment (in contrast 
with for example radionuclides). Creatinine and iohexol have been used frequently in human and veterinary (cat 
and dog) nephrology4,13,14, but not in avian medicine.
The aim of the present study was to assess a reference standard clearance marker, i.e. exogenous exo-iohexol 
and creatinine, to estimate the GFR in six different avian species (broiler chickens, laying chickens, turkeys, 
Muscovy ducks, pigeons and African grey parrots (AGP)). Moreover, the obtained GFR estimations were com-
pared among and correlated between different avian species using both BW and kidney weight (KW) as scaling 
factors.
Results
All birds survived the experiment without any complications. One pigeon was excluded from the study due to 
technical issues during blood sampling. Table 1 summarizes the descriptive statistics of the different bird spe-
cies included in the study. In the presented study, a linear correlation (R² = 0.9836) between BW and KW was 
observed for the five bird species (broiler chicken, laying chicken, turkey, duck and pigeon) for which KW was 
available (Fig. 1). Hence, both KW and BW can be interchangeably used as scaling factors to normalize the GFR 
in birds. This observation was also reflected in Fig. 2A, where allometric scaling demonstrated a good correla-
tion between KW of the five different avian species and clearance of exo-iohexol (R² = 0.8985). The correlation 
between KW of the avian species and clearance of creatinine is less in comparison to the clearance of exo-iohexol 
(R² = 0.7557, Fig. 2B). The mean GFR values indexed to BW of the different markers (mean ± SD) are presented 
in Table 2. Significant differences between the mean renal clearance of creatinine and iohexol were observed 
Species Gender Age Number Bodyweight (kg) Kidney weight (g)
Broiler chicken
♂ 6 weeks 4 3.40 ± 0.16 9.75 ± 4.43
♀ 6 weeks 4 2.68 ± 0.22 7.00 ± 0.82
Laying chicken
♂ 18 weeks 4 2.35 ± 0.13 7.00 ± 1.41
♀ 18 weeks 4 1.50 ± 0.08 6.74 ± 1.89
Turkey
♂ 13 weeks 4 10.7 ± 0.98 33.50 ± 2.38
♀ 13 weeks 4 7.88 ± 0.43 28.50 ± 4.43
Pigeon
♂ 6–12 months 4 0.48 ± 0.04 1.62 ± 0.20
♀ 6–12 months 3 0.42 ± 0.008 2.04 ± 0.17
Duck
♂ 6 months 4 3.23 ± 0.19 15.30 ± 3.14
♀ 6 months 4 1.95 ± 0.19 6.00 ± 0.00
Parrot
♂ 4–20 years 4 0.49 ± 0.05 —
♀ 4–20 years 4 0.45 ± 0.01 —
Table 1. Descriptive statistics of the different bird species. Values are mean ± SD.
3Scientific RepoRtS |         (2019) 9:19699  | https://doi.org/10.1038/s41598-019-56096-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
for all bird species. When comparing the different bird species within each technique, a significant difference 
(p < 0.05) between parrots and three other avian species, namely broiler chickens, laying chickens and turkeys, 
was observed for all techniques. No other significant differences between the GFR values measured with exog-
enous creatinine were noted. The GFR values measured with iohexol significantly differed (p < 0.05) between 
Figure 1. Correlation between mean kidney weight and mean body weight in five different avian species 
(broiler chicken, laying chicken, turkey, duck, and pigeon). Kidneys of the African Grey parrots were not 
collected during this study.
Figure 2. Allometric scaling of kidney weight (g) and exo-iohexol (A), and creatinine (B) clearance (mL/min) 
for five different avian species (broiler chicken, laying chicken, turkey, duck, and pigeon).
Species Creatinine Exo-iohexol
Broiler chicken 8.41 ± 1.63a 3.09 ± 0.65c
Laying chicken 9.33 ± 0.73a 2.57 ± 0.23cd
Turkey 5.62 ± 0.81a 1.94 ± 0.39d
Pigeon 14.97 ± 1.78ab 1.29 ± 0.47ef
Duck 17.59 ± 12.20ab 2.60 ± 0.38c
Parrot 25.56 ± 15.21b 1.11 ± 0.34f
Table 2. Glomerular filtration rate measurements (GFR (mL/min/kg), mean ± SD) using creatinine 
and exo-iohexol in six different avian species (♂/♀). The GFR is indexed to bodyweight. Results with a 
different alphabetical character superscript are considered significantly different (p < 0.05) between the 
different bird species within one technique. For each bird species, the mean renal clearance of creatinine differt 
significantly with the mean renal clearence of iohexol.
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broiler chickens and turkeys, broiler chickens and pigeons, laying chickens and pigeons, pigeons and ducks, ducks 
and parrots, respectively. No significant sex differences were observed. Allometric scaling clearly demonstrated 
a correlation between BW of the different avian species and clearance of exo-iohexol, but less for creatinine 
(R² = 0.8983 and 0.7937, respectively) (Fig. 3A,B).
Discussion
The current study evaluated clearance markers to estimate the GFR in six different avian species. Clearance of 
exo-iohexol normalized to BW (mL/min/kg) was determined in all bird species, which differed significantly with 
the clearance of exogenous creatinine. In birds, a reduction of the GFR can be attributed to renal disease or a 
normal physiologic response to dehydration. When dehydration occurs, the decrease in GFR is intermittent, due 
to the release of arginine vasotocin which causes vasoconstriction of the afferent arteriole of the reptilian-type 
nephrons and inhibition of filtration in these nephrons15. Since the GFR cannot be measured directly, it is esti-
mated based on the clearance of an endogenous or exogenous marker4. In contrast to mammals, in avian species, 
endogenous creatinine cannot be applied as marker because physiological creatinine concentrations are below the 
limit of quantification (LOQ) of frequently used field to lab-assays16,17. Therefore, alternative clearance markers 
should be used to measure GFR in birds. On the other hand, Scope et al.5 demonstrated that IV or IM administra-
tion of exogenous creatinine can be useful for assessing renal creatinine excretion in pigeons, but did not compare 
the obtained results with a gold standard such as inulin or iohexol. In this study in all species, the clearance of 
creatinine was significantly higher than the clearance of exo-iohexol. This was similar to the results obtained in 
healthy and hyperthyroid cats, where significant differences between the mean GFR obtained by creatinine and 
iohexol clearance were observed14,18. The avian renal tubules might secrete creatinine when plasma levels are ele-
vated and reabsorb creatinine when plasma levels are normal, whereby plasma concentration levels of creatinine 
might be confounded19. In the future, iohexol can be used as reference standard to evaluate potential biomarkers 
of early renal dysfunction detection in birds.
Sturkie20 mentioned the mean inulin clearance values of chickens (0.60–3.00 mL/min/kg), ducks (2.5 mL/
min/kg) and doves (2.6 mL/min/kg). These values are in line with the results reported for exo-iohexol in the cur-
rent manuscript (chickens:2.57–3.09 mL/min/kg, ducks: 2.60 mL/min/kg, doves: 1.29 mL/min/kg). The results 
are however not in line with our results observed when administering exogenous creatinine. The GFR values 
obtained using exo-iohexol in broiler and laying chicken were comparable with the results obtained by Radin 
et al.21 and Wideman et al.9, who determined the clearance of inulin in chickens (3.12 ± 0.43 mL/min/kg and 
2.81 ± 0.35 mL/min/kg, respectively). When comparing the creatinine clearance found in this study and the val-
ues obtained by Scope et al.5 in pigeons (6.30 mL/min/kg), the values in the current study (20.90 mL/min/kg) were 
remarkably higher than those of Scope et al.5. The values obtained using exo- iohexol obtained in this study (2.51 
and 1.14 mL/min/kg, respectively), however, were apparently lower. Roberts et al.22 demonstrated variability of 
the GFR values within the same bird species, which might explain the differences observed in the study of Scope 
et al.5 and the current study. Moreover, studies in cats and dogs have shown that GFR values widely differ with 
different techniques (e.g. different clearance markers, different time points, etc.) and different GFR calculation 
models (e.g. one-compartment versus two-compartment versus non-compartment pharmacokinetic models)14,23.
Figure 3. Allometric scaling of body weight (kg) and exo-iohexol (A), and creatinine (B) clearance (mL/min) 
for six different avian species (broiler chicken, laying chicken, turkey, pigeon, duck, and parrot).
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In the current study, the plasma concentration-time curve of iohexol assumes a double-exponential decay 
of the plasma concentrations, representing a two-compartmental model. In most studies, iohexol clearance is 
determined using a two-compartmental model approach, necessitating multiple early and late blood samplings24. 
In clinical practice however, taking multiple blood samples is cumbersome for the patients. Therefore, alter-
native single- and dual-plasma sampling approaches were compared with the traditional urinary clearance or 
multiple-samples plasma clearance approaches. Zhang et al. determined if these new approaches could accurately 
predict iohexol clearances in 170 humans (46 healthy volunteers, 124 chronic kidney disease). The authors con-
cluded that the one-point sampling approach could be applied in patients with a GFR above 60 mL/min/1.73 m², 
but could not be applied in patients with a GFR below 60 mL/min/1.73 m². A prolonged sampling time is required 
in the latter patient group25. The latter was confirmed in children by Tøndel et al. (single: >30 mL/min/1.73 m²; 
double: <30 mL/min/1.73 m²)26. In future studies, the use of single- or double-plasma sampling approaches could 
be evaluated in avian species as well, whereby a mathematical correction for the first fast exponential curve based 
on the slope-intercept method proposed by Brochner-Mortensen could be incorporated27. Also the use of a one, 
versus two versus three compartment model for determining plasma iohexol clearance is topic for debate. As 
mentioned above, most studies apply a two-compartmental model based on the Schwartz approach4, however 
Taubert et al. proposed a three-compartmental model which markedly improved iohexol clearance estimation. 
Further studies are still required to confirm the aptness of this model28.
Since the GFR represents the clearance of a substance by glomerular filtration, scaling of the GFR to a stand-
ard measure of body size should be performed to be able to compare GFR values among different avian species. 
Ideally, the GFR should be scaled using KW, but the availability of KW is clinically not applicable29. Therefore, 
readily available alternative scaling factors, such as BW, body surface area and extracellular fluid volume are fre-
quently used both in human as in veterinary clinical practice. In veterinary clinical practice, BW is the reference 
to normalize the GFR (i.e. cats and dogs). Also in the current study, a linear correlation (R² = 0.9836) between 
BW and KW was observed in the different avian species, rendering BW a suitable scaling factor to compare 
the GFR among these species. In the current study, a clear association between the bird’s BW and the clearance 
of exo-iohexol was demonstrated by allometric scaling (R² = 0.9138 and 0.8983, respectively). Birds with lower 
BW, also have lower GFR values (mL/min). This correlation was less pronounced using exogenous creatinine 
(R² = 0.7937).
Determination of the GFR in avian species is difficult to perform, which brought a number of limitations to 
the study design:
•	 Determination of endogenous creatinine was not possible, since the basal values of creatinine are below the 
LOQ of the enzymatic assay. In the current manuscript it was therefore opted to administer exogenous cre-
atinine to the birds.
•	 The AGP needed to be anaesthetized in order to be able to administer iohexol and creatinine correctly. Anaes-
thetics might lower the GFR, however in the current study design anaesthesia was limited in time and iohexol 
and creatinine were administered after anaesthetic recovery, minimalizing the influence on the GFR.
•	 Urine collection is difficult to perform in avian species, by which the most direct approach to calculate the 
GFR, namely urine concentration*urine flow/plasma concentration, is difficult to apply in these species. 
Therefore, alternative approaches based on plasma concentrations were evaluated in this manuscript cir-
cumventing urine collection. In the future, the alternative approaches should be validated with the direct 
approach, whereby suitable urine collection techniques should be applied.
•	 Collecting larger volumes of blood in smaller avian species (i.e. AGP and pigeons) is ethically not possible. 
In the current manuscript it was opted to lower the sampling volume in these avian species. In even smaller 
avian species, sparse sampling combined with population-PK analysis or dry-blood spots could be suitable 
alternatives to circumvent rich/large blood sampling.
•	 Exogenous iohexol is preferred to creatinine to measure the GFR in avian species. This marker however can-
not be directly used in clinical practice, since a HPLC-UV technique is often not available. Therefore, iohexol 
should be rather used in research to evaluate the potential of other renal function markers which could easily 
be assessed in clinical practice.
In conclusion, the current study determined the GFR in six different avian species. The values obtained with 
exo-iohexol were comparable, but significantly differed with the clearance of exogenous administered creatinine. 
Iohexol is preferred to creatinine to measure the GFR in avian species, since it is not prone to tubular reabsorption 
nor secretion. Iohexol can be used to identify potential biomarkers of early renal dysfunction in avian species.
Materials and Methods
Animals. The current study was in accordance with the national30 and European legislation31 for care and use 
of laboratory animals and was conducted with consent of the ethical committee of the Faculties of Veterinary 
Medicine and Bioscience Engineering of Ghent University (EC2015/155; approval: January 18th, 2016) and 
Comité ético de bienestar animal de GREFA (15/0005; approval: October 30th, 2015). The experiments were 
carried out in clinically healthy broiler chickens (Ross 308, Gallus gallus), laying chickens (Lohmann Brown-
Lite, Gallus gallus dom.), turkeys (Hybrid Converter, Meleagris gallopavo), Muscovy ducks (Cairina moschata), 
pigeons (racing pigeons, Columba livia forma domestica) and AGP (Psittacus erithacus erithacus). The study was 
conducted with eight animals of each avian species (4♂/4♀). All birds were considered to be clinically healthy 
based on physical examination prior and during the experiment, macroscopic examination at necropsy after the 
experiment (except AGP), and regular clinical testing of the AGP (including physical examinations, haematology 
and biochemistry, and polymerase chain reaction analyses for the presence of psittacine circovirus, bornavirus 
and Chlamydia psittaci). All animals were group housed per species, except the AGP (singly housed in 0.9 m by 
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0.9 m by 0.7 m cages), and had ad libitum access to commercial feed and drinking water. The light schedule was 
adapted to 18 hours of light and 6 hours of darkness. The temperature was monitored and kept between 18 and 
25 °C, the relative humidity was between 40 and 80%.
Experimental design. All animals, except the AGP, received iohexol and creatinine by cannulating the 
vena cutanea ulnaris superfacialis (wing vein) with a 25-gauge IV catheter (Terumo versatus winged IV catheter, 
Terumo Europe, Leuven, Belgium). The parrots were first anaesthetized for 5 min with isoflurane (IsoFlo, Abbott 
Laboratories LTD, Madrid, Spain) and oxygen inhalation, followed by catheterization of the vena metatarsalis 
plantaris superficialis (leg vein). After 10 min following recovery from anaesthesia, IV administration to the AGP 
was then performed via a 26-gauge catheter (Terumo Europe). IV administration was performed as follows. First, 
a bolus of 64.7 mg/kg BW (0.1 mL/kg BW) Omnipaque® 300 mg I/mL (GE, Healthcare, Belgium) was adminis-
tered to all species, except pigeons and AGP. Before administratin to the pigeons and the AGP, the Omnipaque® 
solution was diluted four times (1:4) in 0.9% sodium chloride (NaCl). After administration, the IV catheters 
were flushed with an equal volume of 0.9% NaCl. Second, an IV injection of 40 mg/kg BW creatinine hydro-
chloride in 0.9% NaCl solution (Sigma Aldrich, Bornem, Belgium) was immediately administered after iohexol 
to all species and the catheters were flushed according to the iohexol administration. Blood samples (0.5 mL in 
chickens, turkeys, ducks and 0.3 mL in pigeons) of all birds, except the parrots, were collected from the vena 
metatarsalis plantaris superficialis by direct venipuncture (25 G needle) and drawn into heparin collection tubes 
at 0 (before administration) and 5, 15, 30, 60, 120, 180, 360, 480 and 600 min post administration (p.a.). Blood 
sampling of the AGP (0.3 mL) was first performed through the catheter in the metatarsal vein (0, 5, 15, 30 and 
60 min). After 60 min this catheter was removed, and subsequently, blood was withdrawn from the vena jugularis 
by direct venipuncture (30 G needle; 120, 180, 360, 480 and 600 min p.a.). Blood samples were transferred on ice 
and centrifuged for 10 min (2,851 rpm, 4 °C) within two hours after blood collection. Plasma was aliquoted and 
stored at −20 °C until analysis. After euthanasia of the birds (except the parrots) with an overdose of pentobar-
bital (Sodium pentobarbital 20%®, Kela, Hoogstraten, Belgium), both kidneys were removed, dry-dipped and 
weighted to determine the KW.
Laboratory analysis. Exo-iohexol concentrations were determined by a validated high-performance liquid 
chromatography method with ultraviolet detection (HPLC-UV)32. The method was fully validated in broiler 
chicken plasma, followed by a more brief validation in the other avian species. Detailed method validation results 
can be found in Supplementary Material S1. Briefly, 25 µL of the internal standard iohexol impurity J (chemical 
reference substance of the European Pharmacopoeia, Strasbourg, France) were added to 100 µL (chicken, turkey, 
duck) or 50 µL (pigeon, AGP) of plasma, followed by a deproteinization with trifluoroacetic acid (Sigma Aldrich) 
and a centrifugation step (13,000 rpm, 10 min, 4 °C). Exo-iohexol concentrations were assayed after injecting 
50 µL (chicken, turkey, duck) or 20 µL (pigeon, AGP) of the supernatant onto the HPLC-UV instrument. The 
LOQ of exo-iohexol (µg/mL) was as follows: chicken, turkey, duck: 0.46; pigeon, AGP: 0.91. Creatinine concen-
trations were determined by an in-house validated enzymatic method, as described by Van Hoek et al.18, using a 
Catalyst Dx® Chemistry Analyser (Idexx Laboratories, Westbrook, USA). The upper and lower detection limit 
was 1.02 and 135.97 µg/mL, respectively. The method was validated in turkey plasma, followed by a more brief val-
idation in the other avian species. Detailed method validation results can be found in Supplementary Material S2. 
Plasma concentration-time curves were constructed, and the area under the plasma concentration-time curve 
(AUC0->t) of each clearance marker was computed by the trapezoidal rule with extrapolation to infinity using 
non-compartmental pharmacokinetic analysis (WinNonlin® 6.3, Pharsight, Missouri, USA). Plasma clearance of 
exo-iohexol and creatinine were calculated by dividing the dose by the AUC0->t. Allometric scaling was applied 
on the clearance using BW and KW33.
Statistical analysis. The plasma clearances of both markers were compared between avian species (within 
one technique) and between techniques (within one bird species). Within each technique, the effect of bird spe-
cies was analysed using one-way analysis of variance (ANOVA, SPSS 24.0, IBM, USA). Within each bird species, 
the effect of technique was further analysed in a mixed model with repeated measurements on technique. The 
effect of technique was compared between the different sexes. Post hoc comparisons test was performed accord-
ing to Scheffé. The level of significance was set at 0.05. The correlation among BW and KW was quantified by the 
Spearman rank correlation coefficient.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
Received: 24 June 2019; Accepted: 6 December 2019;
Published: xx xx xxxx
References
 1. Pollock, C. Diagnosis and treatment of avian renal disease. Vet. Clin. North. Am. Exot. Anim. Pract. 9(1), 107–128 (2006).
 2. Echols, M. “Evaluating and treating the kidneys”, In: Clinical avian medicine, ed. Harrison, G. J., Lightfoot, T. L., 451–492 (Florida: 
Spix Publishing, Florida, 2006).
 3. Lierz, M. Avian renal disease: pathogenesis, diagnosis, and therapy. Vet. Clin. North. Am. Exot. Anim. Pract. 6, 29–55 (2003).
 4. Schwartz, G. J., Furth, S., Cole, S., Warady, B. & Munoz, A. Glomerular filtration rate via plasma iohexol disappearance: pilot study 
for chronic kidney disease in children. Kidney Int. 69(11), 2070–2077 (2006).
 5. Scope, A., Schwendenwein, I. & Schauberger, G. Plasma exogenous creatinine excretion for the assessment of renal function in avian 
medicine-pharmacokinetic modeling in racing pigeons (Columbia Livia). J. Avian. Med. Surg. 27(3), 173–179 (2013).
7Scientific RepoRtS |         (2019) 9:19699  | https://doi.org/10.1038/s41598-019-56096-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
 6. Dantzler, W. H. & Braun, E. J. Comparative nephron function in reptiles, birds, and mammals. Am. J. Physiol. 239(9), 197–213 
(1980).
 7. Skadhauge, E. & Schmidt-Nielsen, B. Renal function in domestic fowl. Am. J. Physiol. 212(4), 793–798 (1967).
 8. Braun, E. J. & Dantzler, W. H. Function of mammalian-type and reptilian-type nephrons in kidney of desert quail. Am. J. Physiol. 
222(3), 617–629 (1972).
 9. Wideman, R. F., Ford, B. C., May, J. D. & Lott, B. D. Acute heat acclimation and kidney function in broilers. Poult. Sci. 73, 75–88 
(1994).
 10. Gerson, A. R. & Guglielmo, C. G. Measurement of glomerular filtration rate during flight in a migratory bird using a single bolus 
injection of FITC-inulin. Am. J. Physiol. Renal. Physiol. 305(6), F823–829 (2013).
 11. Goldstein, D. L. & Rothschild, E. L. Daily rhythms in rates of glomerular filtration and cloacal excretion in captive and wild song 
sparrows (Melospiza melodia). Physiol. Zool. 66(5), 708–719 (1993).
 12. Rosner, M. H. & Bolton, W. K. Renal function testing. Am J Kidney Dis. 47(1), 174–183 (2006).
 13. Frennby, B. & Sterner, G. Contrast media as marker of GFR. Eur. Radiol. 12(2), 475–484 (2002).
 14. Van Hoek, I. et al. Plasma clearance of exogenous creatinine, exo-iohexol, and endo-iohexol in hyperthyroid cats before and after 
treatment with radioiodine. J. Vet. Intern. Med. 22(4), 879–885 (2008).
 15. Goldstein, D. L. Regulation of the avian kidney by arginine vasotocin. Gen Comp Endocrinol. 147, 78–84 (2005).
 16. Lumeij, J. “Avian clinical biochemistry”, in: Clinical biochemistry of domestic animals, ed. Kaneko, J. et al., 857–884 (San Diego: 
Academic Press, 1997).
 17. Phalen, D. “Avian renal disorders”, In: Laboratory medicine: avian and exotic pets, ed. Fudge, A. 61–68 (Philadelphia: WB Saunders 
Co, 2000).
 18. Van Hoek, I. et al. Comparison and reproducibility of plasma clearance of exogenous creatinine, exo-iohexol, endo-iohexol and 
51Cr-EDTA in young adult and aged healthy cats. J. Vet. Intern. Med. 21, 950–958 (2007).
 19. Klein, B.G. Cunningham’s textbook of veterinary physiology. (Missouri: Elsevier Saunders, 2013).
 20. Sturkie, P. D. Avian Physiology. (Heidelberg: Springer, 1976).
 21. Radin, M. J., Hoepf, T. M. & Swayne, D. E. Use of a single injection solute-clearance method for determination of glomerular 
filtration rate and effective renal plasma flow in chickens. Lab. Anim. Sci. 43, 594–596 (1993).
 22. Roberts, J. R., Baudinette, R. V. & Wheldrake, J. F. Renal clearance studies in stubble quail Coturnix pectoralis and king quail 
Coturnix chinensis under conditions of hydration, dehydration, and salt loading. Physiol. Zool. 58, 340–349 (1985).
 23. Smets, P. M. et al. Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration. PLoS One. 
7(2), e31702 (2012).
 24. Stevens, L. A. & Levey, A. S. Measured GFR as a confirmatory test for estimated GFR. J. Am. Soc. Nephrol. 20(11), 2305–2313 (2009).
 25. Zhang, Y. et al. Accuracy of iohexol plasma clearance for GFR-determination: a comparison between single and dual sampling. BMC 
Nephrol. 19(1), 174 (2018).
 26. Tøndel, C. et al. Iohexol plasma clearance in children: validation of multiple formulas and single-point sampling times. Pediatr. 
Nephrol. 33(4), 683–696 (2018).
 27. Brochner-Mortensen, J. A simple method for the determination of glomerular filtration rate. Scand. J. Clin. Lab. Invest. 30, 271–274 
(1972).
 28. Taubert, M. et al. Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate. 
Sci Rep. 8, 17723 (2018).
 29. Schwartz, G. J. et al. New equations to estimate the GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629–637 (2009).
 30. Belgian Royal Decree. Belgian Royal Decree of 29 May 2013 on the protection of animals used for scientific purposes. Belgisch 
Staatsblad 193, 42808–42912 (2013).
 31. Anonymous. Directive 2010/63/EU of the European Parliament and the Council of 22 September 2010 on the protection of animals 
used for scientific purposes. Official Journal of the European Union, 276, 33–79 (2010).
 32. De Baere, S. et al. Quantitative determination of exo- and endo-iohexol in canine and feline samples using high performance liquid 
chromatography with ultraviolet detection. J. Pharm. Biomed. Anal. 61, 50–56 (2012).
 33. Antonissen, G. et al. Comparative pharmacokinetics and allometric scaling of carboplatin in different avian species. Plos One. 10(7), 
e0134177 (2015).
Acknowledgements
The technical assistance of J. Muyle and J. Lambrecht was gratefully appreciated. The authors gratefully 
appreciated the excellent assistance of many PhD students from the Department of Pharmacology, Toxicology 
and Biochemistry. EG was supported by a doctoral fellowship from the Agency for Innovation by Science and 
Technology in Flanders (IWT) through the ‘SAFEPEDRUG’ project (IWT/SBO 130033). GA is supported by a 
postdoctoral fellowship from the Research Foundation – Flanders (12V6418N).
Author contributions
E.G., A.M., N.C., M.D., S.D.B., M.A., D.P., S.C. and G.A. contributed conception and design of the study. N.C., 
A.M., M.A., G.A. aided in the acquisition of the work. N.C. and S.D.B. performed the HPLC-UV analysis. 
N.C. and D.P. performed the creatinine analysis. E.G. performed the pharmacokinetic and statistical analysis. 
E.G. wrote the first draft of the manuscript. A.M. wrote a section of the manuscript. All authors contributed to 
manuscript revision, read and approved the submitted version.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-019-56096-5.
Correspondence and requests for materials should be addressed to G.A.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
8Scientific RepoRtS |         (2019) 9:19699  | https://doi.org/10.1038/s41598-019-56096-5
www.nature.com/scientificreportswww.nature.com/scientificreports/
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
